These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 35855961)

  • 1. Clinical Features and Duration of Viral Shedding in Individuals With SARS-CoV-2 Omicron Variant Infection.
    Jang YR; Kim JM; Rhee JE; Kim D; Lee NJ; Lee H; Kim JH; Kim EJ; Kim JY
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac237. PubMed ID: 35855961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant.
    Sentis C; Billaud G; Bal A; Frobert E; Bouscambert M; Destras G; Josset L; Lina B; Morfin F; Gaymard A; The Covid-Diagnosis Hcl Study Group
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
    He S; Fang Y; Yang J; Wang W
    Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
    Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.
    Wu Y; Guo Z; Yuan J; Cao G; Wang Y; Gao P; Liu J; Liu M
    Int J Infect Dis; 2023 Apr; 129():228-235. PubMed ID: 36804640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of COVID-19 PCR positivity for Omicron vs earlier variants.
    Kojima N; Roshani A; Klausner JD
    J Clin Virol Plus; 2022 Aug; 2(3):100085. PubMed ID: 35615055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased viral load in patients infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in the Republic of Korea.
    Kim JM; Kim D; Lee NJ; Woo SH; Lee J; Lee H; Park AK; Kim JA; Lee CY; Kim IH; Yoo CK; Kim EJ
    Osong Public Health Res Perspect; 2023 Aug; 14(4):272-278. PubMed ID: 37652682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
    Siedner MJ; Boucau J; Gilbert RF; Uddin R; Luu J; Haneuse S; Vyas T; Reynolds Z; Iyer S; Chamberlin GC; Goldstein RH; North CM; Sacks CA; Regan J; Flynn JP; Choudhary MC; Vyas JM; Barczak AK; Lemieux JE; Li JZ
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34871181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
    Boucau J; Marino C; Regan J; Uddin R; Choudhary MC; Flynn JP; Chen G; Stuckwisch AM; Mathews J; Liew MY; Singh A; Lipiner T; Kittilson A; Melberg M; Li Y; Gilbert RF; Reynolds Z; Iyer SL; Chamberlin GC; Vyas TD; Goldberg MB; Vyas JM; Li JZ; Lemieux JE; Siedner MJ; Barczak AK
    medRxiv; 2022 Mar; ():. PubMed ID: 35262089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis.
    Aoki A; Mori Y; Okamoto Y; Jinno H
    Biol Pharm Bull; 2022 Apr; 45(4):394-396. PubMed ID: 35067489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.
    Kim JM; Rhee JE; Yoo M; Kim HM; Lee NJ; Woo SH; Jo HJ; Kwon D; Lee S; Yoo CK; Kim EJ
    Front Microbiol; 2022; 13():819745. PubMed ID: 35308391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance.
    Ren SY; Wang WB; Gao RD; Zhou AM
    World J Clin Cases; 2022 Jan; 10(1):1-11. PubMed ID: 35071500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
    Sawano M; Takeshita K; Ohno H; Oka H
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
    Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
    Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
    Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
    Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape.
    Sanyaolu A; Marinkovic A; Prakash S; Haider N; Williams M; Okorie C; Badaru O; Smith S
    World J Virol; 2022 May; 11(3):137-143. PubMed ID: 35665238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.